Your browser doesn't support javascript.
loading
Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
Permuth, Jennifer B; Pirie, Ailith; Ann Chen, Y; Lin, Hui-Yi; Reid, Brett M; Chen, Zhihua; Monteiro, Alvaro; Dennis, Joe; Mendoza-Fandino, Gustavo; Anton-Culver, Hoda; Bandera, Elisa V; Bisogna, Maria; Brinton, Louise; Brooks-Wilson, Angela; Carney, Michael E; Chenevix-Trench, Georgia; Cook, Linda S; Cramer, Daniel W; Cunningham, Julie M; Cybulski, Cezary; D'Aloisio, Aimee A; Anne Doherty, Jennifer; Earp, Madalene; Edwards, Robert P; Fridley, Brooke L; Gayther, Simon A; Gentry-Maharaj, Aleksandra; Goodman, Marc T; Gronwald, Jacek; Hogdall, Estrid; Iversen, Edwin S; Jakubowska, Anna; Jensen, Allan; Karlan, Beth Y; Kelemen, Linda E; Kjaer, Suzanne K; Kraft, Peter; Le, Nhu D; Levine, Douglas A; Lissowska, Jolanta; Lubinski, Jan; Matsuo, Keitaro; Menon, Usha; Modugno, Rosemary; Moysich, Kirsten B; Nakanishi, Toru; Ness, Roberta B; Olson, Sara; Orlow, Irene; Pearce, Celeste L.
Afiliação
  • Permuth JB; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Pirie A; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • Ann Chen Y; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Lin HY; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Reid BM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Chen Z; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA.
  • Monteiro A; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Dennis J; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.
  • Mendoza-Fandino G; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
  • Anton-Culver H; Department of Epidemiology, Director of Genetic Epidemiology Research Institute, UCI School of Medicine, University of California Irvine, Irvine, CA, USA.
  • Bandera EV; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
  • Brooks-Wilson A; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver BC, Canada.
  • Carney ME; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada.
  • Chenevix-Trench G; Department of Obstetrics and Gynecology, John A Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA.
  • Cook LS; Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Queensland, Australia.
  • Cramer DW; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA.
  • Cunningham JM; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Cybulski C; Department of Laboratory of Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
  • D'Aloisio AA; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Anne Doherty J; Social and Scientific Systems, Inc, Durham, NC, USA.
  • Earp M; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, NY, USA.
  • Edwards RP; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA.
  • Fridley BL; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Gayther SA; Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee- Womens Research Institute & University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Gentry-Maharaj A; Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA.
  • Goodman MT; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
  • Gronwald J; Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Hogdall E; Cancer Prevention and Control, Samuel Oshin Comprehensive Cancer Institute, Cedars- Sinai Medical Center, Los Angeles, CA, USA.
  • Iversen ES; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Jakubowska A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark and Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Karlan BY; Department of Statistical Science, Duke University, Durham, NC, USA.
  • Kelemen LE; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Kjaer SK; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Kraft P; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California.
  • Le ND; Department of Public Health Sciences, Medical University of South Carolina College of Medicine, Charleston, SC, USA.
  • Levine DA; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Lissowska J; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Lubinski J; Program in Genetic Epidemiology and Statistical Genetics, Harvard TH Chan School of Public Health, Boston, MA, USA.
  • Matsuo K; Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada.
  • Menon U; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Modugno R; Department of Cancer Epidemiology and Prevention, The Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland.
  • Moysich KB; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Nakanishi T; Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
  • Ness RB; Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Olson S; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Orlow I; Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee- Womens Research Institute & University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
  • Pearce CL; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA.
Hum Mol Genet ; 25(16): 3600-3612, 2016 08 15.
Article em En | MEDLINE | ID: mdl-27378695

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Actinas / Neoplasias Epiteliais e Glandulares / Biotinidase / Receptor Tipo 2 de Melanocortina / Queratina-13 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Actinas / Neoplasias Epiteliais e Glandulares / Biotinidase / Receptor Tipo 2 de Melanocortina / Queratina-13 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article